{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:24:04Z","timestamp":1761218644900,"version":"3.38.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ctro.2024.100753","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:23:08Z","timestamp":1708687388000},"page":"100753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical results of a multicenter study"],"prefix":"10.1016","volume":"45","author":[{"given":"B.","family":"Salas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ferrera-Alay\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Espinosa-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vera-Rosas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kannemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alayon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Chicas-Sett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"LLoret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.C.","family":"Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"43","key":"10.1016\/j.ctro.2024.100753_b0005","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.ctro.2024.100753_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102480","article-title":"Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer\u2014A Critical Review and Practical Consideration","volume":"10","author":"Burko\u0148","year":"2022","journal-title":"Biomedicines"},{"issue":"Suppl 3","key":"10.1016\/j.ctro.2024.100753_b0015","first-page":"41","article-title":"New Potential Options for SBRT in Pancreatic Cancer","volume":"4","author":"Ghaly","year":"2021","journal-title":"Cancer Med J [internet]"},{"key":"10.1016\/j.ctro.2024.100753_b0020","doi-asserted-by":"crossref","unstructured":"Suker M, Nuyttens JJ, Eskens FALM, Haberkorn BCM, Coene PPLO, van der Harst E, et al. Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial). EClinicalMedicine [Internet]. 2019;17:100200. Available from: 10.1016\/j.eclinm.2019.10.013.","DOI":"10.1016\/j.eclinm.2019.10.013"},{"issue":"42","key":"10.1016\/j.ctro.2024.100753_b0025","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.3748\/wjg.v19.i42.7461","article-title":"Combined radiochemotherapy in patients with locally advanced pancreatic cancer: A meta-analysis","volume":"19","author":"Chen","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ctro.2024.100753_b0030","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4143\/crt.2015.226","article-title":"Concurrent chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: A retrospective cohort study","volume":"48","author":"Choi","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ctro.2024.100753_b0035","unstructured":"Rainer Fietkau, Michael Ghadimi, Robert Gr\u20acutzmann, Uwe A Wittel, Lutz Jacobasch W, Uhl, Roland S. Croner, Wolf Otto Bechstein, Ulf Peter Neumann, Dirk Waldschmidt SH, Boeck, Nicolas Moosmann, Anke C. Reinacher-Schick, Henriette Golcher, Werner Adler S, Semrau, Annett Kallies, Markus Hecht, Andrea Tannapfel HO. Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: First results of the CONKO-007 trial. Gastrointest CANCER\u2014GASTROESOPHAGEAL, PANCREATIC, HEPATOBILIARY."},{"issue":"7","key":"10.1016\/j.ctro.2024.100753_b0040","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.3390\/curroncol30070513","article-title":"Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)","volume":"30","author":"Comito","year":"2023","journal-title":"Curr Oncol"},{"issue":"24","key":"10.1016\/j.ctro.2024.100753_b0045","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1001\/jama.2009.886","article-title":"Body mass index and risk, age of onset, and survival in patients with pancreatic cancer","volume":"301","author":"Li","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ctro.2024.100753_b0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.21873\/anticanres.13975","article-title":"Higher biologically effective dose predicts survival in SBRT of pancreatic cancer: A multicentric analysis (PAULA-1)","volume":"40","author":"Arcelli","year":"2020","journal-title":"Anticancer Res"},{"issue":"December","key":"10.1016\/j.ctro.2024.100753_b0055","first-page":"1","article-title":"Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar","volume":"10","author":"Mazzarotto","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2024.100753_b0060","unstructured":"1 NS, 1 RM, Paiella S, Guariglia S, Zivelonghi E, Malleo G, et al. Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma. Clin Oncol. 2020."},{"issue":"23","key":"10.1016\/j.ctro.2024.100753_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers14235725","article-title":"Advances in Radiation Oncology for Pancreatic Cancer: An Updated Review","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2024.100753_b0070","unstructured":"Mary Feng, M.D.1, James M. Balter, Ph.D.1, Daniel Normolle, Ph.D.1 SA, M.D.2, Yue Cao, Ph.D.1, Thomas L. Chenevert, Ph.D.2, and Edgar Ben-Josef MD. Characterization of Pancreatic Tumor Motion Using Cine- MRI: Surrogates for Tumor Position Should be Used with Caution. Int J Radiat Oncol Biol Phys. 2009."},{"issue":"11","key":"10.1016\/j.ctro.2024.100753_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112688","article-title":"Stereotactic Ablative Radiotherapy Using CALYPSO\u00ae Extracranial Tracking for Intrafractional Tumor Motion Management\u2014A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective Study","volume":"14","author":"Kau\u010di\u0107","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ctro.2024.100753_b0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2016.07.012","article-title":"Comparative evaluation of respiratory-gated and ungated FDG-PET for target volume definition in radiotherapy treatment planning for pancreatic cancer","volume":"120","author":"Kishi","year":"2016","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2024.100753_b0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/acm2.12577","article-title":"Intrafraction tumor motion during deep inspiration breath hold pancreatic cancer treatment","volume":"20","author":"Zeng","year":"2019","journal-title":"J Appl Clin Med Phys"},{"issue":"12","key":"10.1016\/j.ctro.2024.100753_b0090","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00066-016-1057-x","article-title":"Simultan integrierte Protektion: Ein neues Konzept f\u00fcr die Hochpr\u00e4zisionsbestrahlung","volume":"192","author":"Brunner","year":"2016","journal-title":"Strahlentherapie Und Onkol"},{"issue":"11","key":"10.1016\/j.ctro.2024.100753_b0095","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00066-023-02085-7","article-title":"Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities","volume":"199","author":"Gkika","year":"2023","journal-title":"Strahlentherapie Und Onkol"},{"key":"10.1016\/j.ctro.2024.100753_b0100","unstructured":"Eugene J. Koay MD, PhD a 1, Alexander N. Hanania MD, MPH b 1, William A. Hall MD c, Cullen M. Taniguchi MD, PhD a, Neal Rebueno CMD a, Sten Myrehaug MD d, Katharine L. Aitken MD e, Laura A. Dawson MD f, Christopher H. Crane MD g, Joseph M. Herman MD a BEM c. Clinical Investigation Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach. Pract Radiat Oncol. 2020;10(6):e495\u2013507."},{"key":"10.1016\/j.ctro.2024.100753_b0105","doi-asserted-by":"crossref","unstructured":"Yang W, Reznik R, Fraass BA, Nissen N, Hendifar A, Wachsman A, et al. Dosimetric evaluation of simultaneous integrated boost during stereotactic body radiation therapy for pancreatic cancer. Med Dosim [Internet]. 2015;40(1):47\u201352. Available from: http:\/\/dx.doi.org\/10.1016\/j.meddos.2014.09.001.","DOI":"10.1016\/j.meddos.2014.09.001"},{"issue":"5","key":"10.1016\/j.ctro.2024.100753_b0110","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/cam4.2100","article-title":"Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer","volume":"8","author":"Rudra","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ctro.2024.100753_b0115","doi-asserted-by":"crossref","unstructured":"Hassanzadeh C, Rudra S, Bommireddy A, Hawkins WG, Wang-Gillam A, Fields RC, et al. Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation. Adv Radiat Oncol [Internet]. 2021;6(1):100506. Available from: 10.1016\/j.adro.2020.06.010.","DOI":"10.1016\/j.adro.2020.06.010"},{"key":"10.1016\/j.ctro.2024.100753_b0120","doi-asserted-by":"crossref","unstructured":"Chuong MD, Bryant J, Mittauer KE, Hall M, Kotecha R, Alvarez D, et al. Ablative 5-Fraction Stereotactic Magnetic Resonance\u2013Guided Radiation Therapy With On-Table Adaptive Replanning and Elective Nodal Irradiation for Inoperable Pancreas Cancer. Pract Radiat Oncol [Internet]. 2021;11(2):134\u201347. Available from: 10.1016\/j.prro.2020.09.005.","DOI":"10.1016\/j.prro.2020.09.005"},{"key":"10.1016\/j.ctro.2024.100753_b0125","doi-asserted-by":"crossref","unstructured":"Parikh PJ, Lee P, Low DA, Kim J, Mittauer KE, Bassetti MF, et al. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance\u2013Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer. Int J Radiat Oncol [Internet]. 2023;000(00). Available from: 10.1016\/j.ijrobp.2023.05.023.","DOI":"10.1016\/j.ijrobp.2023.05.023"},{"issue":"11","key":"10.1016\/j.ctro.2024.100753_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15112916","article-title":"Clinical Applications of Magnetic Resonance-Guided Radiotherapy: A Narrative Review","volume":"15","author":"Ladbury","year":"2023","journal-title":"Cancers (basel)"},{"year":"2010","series-title":"AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual","author":"Edge","key":"10.1016\/j.ctro.2024.100753_b0135"},{"key":"10.1016\/j.ctro.2024.100753_b0140","unstructured":"Stephen B. Edge, David R. Byrd, Carolyn C. Compton, April G. Fritz, Frederick L. Greene AT. AJCC Cancer Staging Handbook From the AJCC Cancer Staging Manual. 2010."},{"issue":"10","key":"10.1016\/j.ctro.2024.100753_b0145","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1118\/1.2349696","article-title":"The management of respiratory motion in radiation oncology report of AAPM Task Group 76","volume":"33","author":"Keall","year":"2006","journal-title":"Med Phys"},{"issue":"42","key":"10.1016\/j.ctro.2024.100753_b0150","doi-asserted-by":"crossref","first-page":"7387","DOI":"10.3748\/wjg.v27.i42.7387","article-title":"Long-term clinical outcomes of lipiodol marking using standard gastroscopy for image-guided radiotherapy of upper gastrointestinal cancers","volume":"27","author":"Be","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ctro.2024.100753_b0155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1590\/S1677-5538.IBJU.2014.02.08","article-title":"Lipiodol as a fiducial marker for image-guided radiation therapy for bladder cancer","volume":"40","author":"Freilich","year":"2014","journal-title":"Int Braz J Urol"},{"issue":"1","key":"10.1016\/j.ctro.2024.100753_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-023-02874-5","article-title":"Comparison of metal versus plastic stent for preoperative biliary drainage in patients with pancreatic cancer undergoing neoadjuvant therapy: a meta-analysis and systematic review","volume":"23","author":"Lyu","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ctro.2024.100753_b0165","doi-asserted-by":"crossref","unstructured":"Eric Pepin PhD a b, Lindsey Olsen MS b, Shahed Badiyan MD b, Faris Murad MD b, Daniel Mullady MD b, Andrea Wang-Gillam MD b, David Linehan MD b, Parag Parikh MD b JOM. Comparison of implanted fiducial markers and self-expandable metallic stents for pancreatic image guided radiation therapy localization. Pract Radiat Oncol. 2015;5(3):e193\u20139.","DOI":"10.1016\/j.prro.2014.08.019"},{"issue":"24","key":"10.1016\/j.ctro.2024.100753_b0170","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.3748\/wjg.v20.i24.7864","article-title":"Imaging diagnosis of pancreatic cancer: A state-of-the-art review","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ctro.2024.100753_b0175","doi-asserted-by":"crossref","unstructured":"Thomas B. Brunner a, Karin Haustermans b, Florence Huguet c d, Alessio G. Morganti e, Somnath Mukherjee f g, Claus Belka h, Robert Krempien j, Maria A. Hawkins k, Vincenzo Valentini m l FR i. ESTRO ACROP guidelines for target volume definition in pancreatic cancer. Radiother Oncol. 2021;154:60\u20139.","DOI":"10.1016\/j.radonc.2020.07.052"},{"key":"10.1016\/j.ctro.2024.100753_b0180","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s11547-021-01441-w","article-title":"A non-surgical COMBO-therapy approach for locally advanced unresectable pancreatic adenocarcinoma: preliminary results of a prospective study","volume":"127","author":"Parisi","year":"2022","journal-title":"Radiol Med"},{"issue":"1","key":"10.1016\/j.ctro.2024.100753_b0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A Story of Hypofractionation and the Table on the Wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys [internet]"},{"key":"10.1016\/j.ctro.2024.100753_b0190","unstructured":"U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE).v.5.0. Cancer Ther Eval Progr [Internet]. 2017;155. Available from: http:\/\/upen.terengganu.gov.my\/index.php\/2017."},{"issue":"1","key":"10.1016\/j.ctro.2024.100753_b0195","first-page":"1","article-title":"Criterios de Evaluaci\u00f3n en Tumores S\u00f3lidos 1.1 (RECIST 1.1) en pacientes con C\u00e1ncer Primario y\/o Metast\u00e1sico o Enfermedad Metast\u00e1sica Recurrente","volume":"April 2019","author":"Jimenez","year":"2018","journal-title":"Rev Sci"},{"key":"10.1016\/j.ctro.2024.100753_b0200","doi-asserted-by":"crossref","unstructured":"Parikh PJ, Lee P, Low D, Kim J, Mittauer KE, Bassetti MF, et al. Stereotactic MR-Guided On-Table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Locally Advanced Pancreatic Cancer: Primary Endpoint Outcomes of a Prospective Phase II Multi-Center International Trial. Radiat Oncol Biol. 2022;.","DOI":"10.1016\/j.ijrobp.2022.09.010"},{"key":"10.1016\/j.ctro.2024.100753_b0205","doi-asserted-by":"crossref","unstructured":"Stephen Chin, Cynthia L Eccles, Alan McWilliam, Robert Chuter, Emma Walker, Philip Whitehurst, Joseph Berresford, Marcel Van Herk, Peter J Hoskin AC. Magnetic resonance-guided radiation therapy: A review. J Med Imaging Radiat Oncol. 2019.","DOI":"10.1111\/1754-9485.12968"},{"issue":"17","key":"10.1016\/j.ctro.2024.100753_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11175136","article-title":"Emergence of MR-Linac in Radiation Oncology: Successes and Challenges of Riding on the MRgRT Bandwagon","volume":"11","author":"Das","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ctro.2024.100753_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-8-148","article-title":"SBRT in unresectable advanced pancreatic cancer: Preliminary results of a mono-institutional experience","volume":"8","author":"Tozzi","year":"2013","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2024.100753_b0220","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejso.2016.12.012","article-title":"Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study","volume":"43","author":"Comito","year":"2017","journal-title":"Eur J Surg Oncol [internet]"},{"issue":"7","key":"10.1016\/j.ctro.2024.100753_b0225","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cncr.29161","article-title":"Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma","volume":"121","author":"Herman","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ctro.2024.100753_b0230","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2021.02.008","article-title":"Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer","volume":"110","author":"Courtney","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys [internet]"},{"issue":"7","key":"10.1016\/j.ctro.2024.100753_b0235","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/0284186X.2015.1004367","article-title":"Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma","volume":"54","author":"Mellon","year":"2015","journal-title":"Acta Oncol (madr)"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T02:42:33Z","timestamp":1742179353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630824000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"alternative-id":["S2405630824000302"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100753","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical results of a multicenter study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100753"}}